Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Ono Pharmaceutical Co., Ltd.
  6. Financials
    4528   JP3197600004

ONO PHARMACEUTICAL CO., LTD.

(4528)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization1 1 115 1281 240 8111 442 5211 349 484--
Entreprise Value (EV)1 1 045 8601 179 5531 378 4981 248 6441 206 1701 150 598
P/E ratio 21,6x21,0x19,1x16,1x13,3x11,1x
Yield 2,07%1,81%1,73%2,03%2,32%2,52%
Capitalization / Revenue 3,86x4,24x4,66x3,86x3,41x3,04x
EV / Revenue 3,62x4,03x4,46x3,58x3,05x2,59x
EV / EBITDA 14,4x12,9x12,1x10,1x8,15x6,59x
Price to Book 2,00x2,21x2,27x1,95x1,77x1,60x
Nbr of stocks (in thousands) 514 121499 120499 142499 162--
Reference price (JPY) 2 1692 4862 8902 7042 7042 704
Announcement Date 05/09/201905/12/202005/11/2021---
1 JPY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales1 288 634292 420309 284349 194395 417444 245
EBITDA1 72 63191 705114 150123 860148 030174 726
Operating profit (EBIT)1 62 01077 49198 330107 987132 046158 208
Operating Margin 21,5%26,5%31,8%30,9%33,4%35,6%
Pre-Tax Profit (EBT)1 65 14179 696100 890109 697133 287155 042
Net income1 51 53959 70475 42584 105101 272121 423
Net margin 17,9%20,4%24,4%24,1%25,6%27,3%
EPS2 100118151168203243
Dividend per Share2 45,045,050,055,062,868,0
Announcement Date 05/09/201905/12/202005/11/2021---
1 JPY in Million
2 JPY
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3
Net sales1 84 45974 35187 36383 969166 70091 000
EBITDA ------
Operating profit (EBIT)1 29 78816 14129 79227 20354 15027 900
Operating Margin 35,3%21,7%34,1%32,4%32,5%30,7%
Pre-Tax Profit (EBT)1 30 98416 23230 80427 30056 60028 500
Net income1 26 6388 93824 07420 04043 50020 930
Net margin 31,5%12,0%27,6%23,9%26,1%23,0%
EPS2 53,417,948,242,287,144,5
Dividend per Share ------
Announcement Date 02/01/202105/11/202107/30/2021---
1 JPY in Million
2 JPY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 69 26861 25864 023100 840143 313198 885
Leverage (Debt / EBITDA) -0,95x-0,67x-0,56x-0,81x-0,97x-1,14x
Free Cash Flow1 17 01166 68216 39159 58982 751100 476
ROE (Net Profit / Equities) 9,50%10,7%12,6%12,7%14,2%15,0%
Shareholders' equity1 542 516557 981598 611661 406715 497808 786
ROA (Net Profit / Asset) 10,3%12,0%14,2%11,7%12,4%13,1%
Assets1 500 145497 621530 900719 910815 525927 348
Book Value Per Share2 1 0841 1271 2731 3841 5261 693
Cash Flow per Share2 121147183182216255
Capex1 22 3037 4757 01819 21817 24717 033
Capex / Sales 7,73%2,56%2,27%5,50%4,36%3,83%
Announcement Date 05/09/201905/12/202005/11/2021---
1 JPY in Million
2 JPY
Key data
Capitalization (JPY) 1 349 483 653 246
Capitalization (USD) 12 280 648 787
Net sales (JPY) 309 284 000 000
Net sales (USD) 2 811 391 560
Number of employees 3 607
Sales / Employee (JPY) 85 745 495
Sales / Employee (USD) 779 427
Free-Float 77,2%
Free-Float capitalization (JPY) 1 042 010 075 916
Free-Float capitalization (USD) 9 482 560 047
Avg. Exchange 20 sessions (JPY) 2 916 481 730
Avg. Exchange 20 sessions (USD) 26 510 819
Average Daily Capital Traded 0,2%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA